Prime Medicine News

Prime Medicine | ARS: Annual Report to Security Holders

Apr 29 16:17 ET

Prime Medicine | DEFA14A: Others

Apr 29 16:11 ET

Prime Medicine | DEF 14A: Definitive information statements

Apr 29 16:09 ET

Prime Medicine | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 19 16:10 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Director Marrazzo Jeffrey D

Mar 4 21:21 ET

Prime Medicine | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 1 08:14 ET

Prime Medicine | 10-K: Annual report

Mar 1 08:06 ET

Prime Medicine | 8-K: Current report

Mar 1 08:06 ET

Prime Medicine | 3: Initial statement of beneficial ownership of securities- GV 2023 GP, L.L.C.

Feb 29 16:28 ET

Prime Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alphabet Holdings LLC(12.2%),XXVI Holdings Inc.(12.2%), etc.

Feb 29 16:21 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Gottesdiener Keith Michael

Feb 27 09:40 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Goldwasser Meredith

Feb 23 17:12 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer LEE ANN L.

Feb 23 17:12 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Duffield Jeremy

Feb 23 17:12 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Brudnick Richard

Feb 23 17:10 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Alenson Carman

Feb 23 17:06 ET

Prime Medicine | SC 13D: Statement of acquisition of beneficial ownership by individuals-ARCH Venture Fund X, L.P.(12.9%),ARCH Venture Fund X Overage, L.P.(12.9%), etc.

Feb 22 21:33 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT

Feb 20 17:44 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners XII, LLC

Feb 20 17:44 ET

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners X, LLC

Feb 20 17:40 ET